Home / Conditions / Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus: when insurers say no, reviewers often say yes

In 79 published external-review decisions involving type 2 diabetes mellitus, independent physician reviewers overturned the insurer’s denial 78.5% of the time.

Published decisions
79
2001–2026
Overturned
78.5%
62 denials reversed

Most-fought treatments for type 2 diabetes mellitus

What insurers denied — and how those fights ended.
TreatmentDecisionsOverturned
Mounjaro29
89.7%
Ozempic12
83.3%
How to use this in your appeal

These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for type 2 diabetes mellitus was denied, the published record says the denial is worth fighting.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for type 2 diabetes mellitus? 78.5% won.

Explain my denial — free